Skip to content

Nilogen and Scailyte Are Joining Forces to Find the “Right” Treatment for Every Patient

nilogen and scailyte joining forces

TAMPA, FL and BASEL, SWITZERLAND July 12, 2022. Nilogen Oncosystems, a leading Oncology drug development Company; and Scailyte, a single cell AI biomarker discovery company, announced today a strategic partnership to increase the success rate of novel cancer therapies in the clinic, as well as to advance personalized cancer treatment.

This long-term strategic partnership aims at integrating Nilogen Oncosytems’ proprietary 3D-EXplore Platform of fresh patient tumor tissue with Scailyte’s AI Platform ScaiVision™ to develop a robust cutting-edge omics engine for personalized drug-tumor interactions to understand drug MoA and predict tumor response in patients for clinical trials enrichment.     

The joint platform will unlock new paradigms in drug discovery and development thanks to Nilogen Oncosytems’ unique 3D EXplore tumoroid technology retaining the intact tumor microenvironment, and to the ability of ScaiVision™ to detect complex, ultra-sensitive, and predictive molecular signatures in biological samples.

“Nilogen Oncosystems’ capability to generate omics and multi-modal data from each therapeutic option and for each patient is unique.  This capability in combination with Scailyte’s ability to unlock molecular insights with single cell resolution creates an unprecedented level of personalized information and precision. This will not just change the way we discover and develop novel therapies, but more importantly will save more lives”, said Juana Lucia Flores-Candia, PhD, MBA, VP Strategy & Business Development at Scailyte. 

We are pleased to be working with Scailyte since I believe our integrated solutions will not only support our BioPharma clients for faster, data-driven decision making throughout their drug development process, but will also allow us to advance precision medicine applications for the treatment of cancer patients”, said Soner Altiok, MD, PhD, Chief Scientific Officer at Nilogen Oncosystems.

About Nilogen Oncosystems

Founded in 2013, Nilogen Oncosystems, LLC is an Oncology drug development company with CLIA certified facilities in Tampa, FL. At Nilogen, we appreciate the complexity of cancer and use fresh patient tumor samples with intact tumor immune microenvironment in our 3D-EXplore preclinical drug testing platform. This holistic approach allows us to develop integrated solutions for a better understanding of the molecular mechanisms of drug sensitivity and resistance. Our goal is to enable the development of more effective drug and drug combinations, and reduce the cost and risk associated with clinical trials. Nilogen’s commitment to testing and customizing cancer drug development is proven and yields unparalleled results for its clients. 

For more information, visit www.nilogen.com and connect on social media @LinkedIn.

About Scailyte

Scailyte AG is a spin-off of ETH Zurich and combines single-cell technologies, high-quality datasets and machine learning methods to identify disease-specific biomarkers, with focus on oncology and immunology. Scailyte’s proprietary best-in-class data analysis platform ScaiVision associates multimodal single-cell datasets (RNA-/TCR-/BCR-seq, proteomics, etc) with clinical endpoints, such as disease diagnosis, progression, severity, treatment response, in order to identify ultra-sensitive biomarker signatures. Thanks to the single-cell resolution and AI-driven approach, ScaiVision is the most powerful and cutting-edge approach to precise diagnosis and prediction of therapy response. Scailyte leverages a broad network of top clinicians to identify clinical indications with high unmet clinical needs and collaborates with global pharmaceutical and biotech companies to translate the novel biomarkers into ultra-sensitive companion diagnostics (CDx) or IVD assays. 

For more information, visit www.scailyte.com and connect on social media @LinkedIn and @Twitter.

ScailyteTM and ScaiVisionTM are registered trademarks proprietary to Scailyte AG.

Recent News

Meet Scailyte at Immuno-Oncology 360° in New York, USA

Our very own Diana Stoycheva and Peter Nestorov will be representing Scailyte at the conference at b...

Read more

Recent News

Inside Scailyte – Episode 5: Meet Daniel Schoener

Join us as we introduce you to Daniel Schoener, Executive Business Advisor at Scailyte AG. Daniel's ...

Read more

Recent News

ScaiDigest Volume 7: Unveiling Insights into Autoimmune Diseases

We're thrilled to share the latest installment of our ScaiDigest series, authored by our very own Di...

Read more

Recent News

Inside Scailyte – Episode 4: Meet Peter Evans

In this special episode, we introduce you to Peter Evans, our Principal IT Engineer at Scailyte AG. ...

Read more

Recent News

Inside Scailyte – Episode 3: Meet Peter Nestorov

Join us as Peter Nestorov, the Founder and CEO of Scailyte shares the pivotal role of Scailyte in th...

Read more

Recent News

Festival of Genomics 2024

Scailyte will be a part of the upcoming Festival of Genomics, on January 24th and 25th, 2024, in Lon...

Read more

Recent News

Inside Scailyte - Episode 2: Filipa Teixeira

We're back with another exciting episode of "Inside Scailyte," where we delve into the incredible jo...

Read more

Recent News

Single-cell omics and Al-fueled discovery to help endometriosis patients

Scailyte's powerful single-cell AI platform, ScaiVision, has played a pivotal role in a groundbreaki...

Read more

Recent News

01 /04

Meet Scailyte at Immuno-Oncology 360° in New York, USA

Our very own Diana Stoycheva and Peter Nestorov will be representing Scailyte at the conference at b...

Read more

Inside Scailyte – Episode 5: Meet Daniel Schoener

Join us as we introduce you to Daniel Schoener, Executive Business Advisor at Scailyte AG. Daniel's ...

Read more

Recent News

02 /04

ScaiDigest Volume 7: Unveiling Insights into Autoimmune Diseases

We're thrilled to share the latest installment of our ScaiDigest series, authored by our very own Di...

Read more

Inside Scailyte – Episode 4: Meet Peter Evans

In this special episode, we introduce you to Peter Evans, our Principal IT Engineer at Scailyte AG. ...

Read more

Recent News

03 /04

Inside Scailyte – Episode 3: Meet Peter Nestorov

Join us as Peter Nestorov, the Founder and CEO of Scailyte shares the pivotal role of Scailyte in th...

Read more

Festival of Genomics 2024

Scailyte will be a part of the upcoming Festival of Genomics, on January 24th and 25th, 2024, in Lon...

Read more

Recent News

04 /04

Inside Scailyte - Episode 2: Filipa Teixeira

We're back with another exciting episode of "Inside Scailyte," where we delve into the incredible jo...

Read more

Single-cell omics and Al-fueled discovery to help endometriosis patients

Scailyte's powerful single-cell AI platform, ScaiVision, has played a pivotal role in a groundbreaki...

Read more

Recent News